Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.41 |
| ▸ | DRD3 | P35462 | 3/20 | 0.41 |
| ▸ | HTR1A | P08908 | 2/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.41 |
| ▸ | DRD1 | P21728 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17930135 | 0.89 | SIGMAR1 (0.49) | SIGMAR1KCNH2DRD3HTR1ACHRM1 | |
| SCHEMBL19530997 | 0.85 | CYP3A4 (0.43) | KDM4EHTR2AHRH1CYP3A4 | |
| SCHEMBL2359631 | 0.81 | TP53 (0.36) | SIGMAR1TSHRDRD3HTR1AOPRM1 | |
| SCHEMBL9864179 | 0.81 | CYP3A4 (0.39) | SIGMAR1TSHRKCNH2DRD3HTR1A | |
| SCHEMBL17190349 | 0.79 | TAAR1 (0.45) | SIGMAR1TSHRKCNH2DRD3CHRM1 | |
| SCHEMBL17598759 | 0.78 | TDP1 (0.43) | SIGMAR1KCNH2DRD3HTR1ACHRM1 | |
| SCHEMBL17190351 | 0.74 | LTA4H (0.39) | SIGMAR1TSHRKCNH2CHRM1SLC6A4 | |
| SCHEMBL8723759 | 0.74 | SIGMAR1 (0.42) | SIGMAR1TSHRKCNH2DRD3HTR1A | |
| SCHEMBL10314926 | 0.74 | KCNH2 (0.46) | SIGMAR1KCNH2DRD3OPRM1DRD2 | |
| SCHEMBL11292500 | 0.74 | CARM1 (0.42) | HTR2ASMN1; SMN2ADRA2CHRH1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9731282-B2 | Ligand compound, organic chromium compound, catalyst system for ethylene oligomerization, preparation method thereof, and ethylene oligomerization method using the same | LG CHEM, LTD. (KR) | 2017-08-15 | — | — | US | disclosed |
| US-9731282-B2 | Ligand compound, organic chromium compound, catalyst system for ethylene oligomerization, preparation method thereof, and ethylene oligomerization method using the same | LG CHEM, LTD. (KR) | 2017-08-15 | — | — | US | disclosed |
| US-20150298110-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, CATALYST SYSTEM FOR ETHYLENE OLIGOMERIZATION, PREPARATION METHOD THEREOF, AND ETHYLENE OLIGOMERIZATION METHOD USING THE SAME | LG CHEM, LTD. (KR) | 2015-10-22 | — | — | US | disclosed |
| US-20150298110-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, CATALYST SYSTEM FOR ETHYLENE OLIGOMERIZATION, PREPARATION METHOD THEREOF, AND ETHYLENE OLIGOMERIZATION METHOD USING THE SAME | LG CHEM, LTD. (KR) | 2015-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150298110-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, CATALYST SYSTEM FOR ETHYLENE OLIGOMERIZATION, PREPARATION METHOD THEREOF, AND ETHYLENE OLIGOMERIZATION METHOD USING THE SAME | OXER1, ORC3, OR51E2 | SIGMAR1 819/4885TSHR 2735/4885KCNH2 3102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.